The Weekly Roundup: August 8-12

POLL: Which Most Recent FDA Approval Are You Excited About?

Click here to answer this week's poll.

The Mainstream Patient: August 8

This week's edition of the Mainstream Patient features stories about hormonal acne, body scrubs, vitamin C serum to fight hyperpigmentation, and more.

He Is my Covering Physician. Why Am I Being Sued?

In this month's Legal Eagle, David J. Goldberg, MD, JD, discusses a legal situation involving an oculoplastic surgeon and a covering physician.

Setting Expectations About Treatments With Patients

Three experts emphasize the importance of setting expectations for AD treatment with patients.

AD Patient Case: FST I

Experts discuss the case of a 4-year-old girl with lighter skin and treatment options for a young child.

Banana Boat Hair & Scalp Sunscreen Spray SPF 30 Recalled

Edgewell Personal Care Company issued a voluntary national recall of 3 collections of Banana Boat Hair & Scalp Sunscreen due to the presence of benzene.

Acne Updates: Pearls on Treating Acne from a Recent Maui Derm Conference

Julie Harper, MD, a board-certified dermatologist in private practice in Birmingham, Alabama, a founding director and past president of the American Acne and Rosacea Society, gave a presentation on acne treatment updates at the Maui Derm NP+PA Summer 2022 conference.

Protecting a Physician’s Most Valuable Asset: Insurance Basics for Young Dermatologists

Jason M. O'Dell, MS, CWM, and Michael Lewellen, CFP, discuss what young dermatologists need to know about insurance basics to protect themselves.

Pointers with Dr Portela: Interview with Josh Zeichner, MD

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Josh Zeichner, MD, and discusses Jori Skincare.

FDA Issues 3 Warning Letters to Companies Selling Unapproved Drugs for Mole and Skin Tag Removal

Amazon, Ariella Naturals, and Justified Laboratories received warning letters from the FDA.

Focusing on Feet

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, participates in a Q&A about dry and cracked feet.

When to Progress to Systemic Therapy

Eric Simpson, MD, MCR, and professor of dermatology at Oregon Health & Science University presents exciting new systemic therapy treatment options for atopic dermatitis.

Phase 2a FMX114 Study for AD Did Not Meet Primary Endpoints

VYNE Therapeutics Inc. announced the results of study VY2021-01.

Characteristics of Type 2 Inflammation and the Impact of Itch

Joshua Zeichner, MD, and Vikash Oza, MD, discuss characteristics of type 2 inflammation and the impact of itching on pediatric patients with atopic dermatitis.

Mechanism of Action for Agents Used to Treat Pediatric Atopic Dermatitis

Joshua Zeichner, MD, and Raj Chovatiya, MD, PhD, dive deep into the pathogenesis of atopic dermatitis and discuss how agents treating atopic dermatitis work.

Psychological Impact of Atopic Dermatitis in Pediatric Patients

Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the psychological factors impacting pediatric patients’ atopic dermatitis.

Presentation and Diagnosis of Atopic Dermatitis in Pediatrics

Brittany Craiglow, MD; Raj Chovatiya, MD, PhD; and Joshua Zeichner, MD, discuss the presentation of pediatric patients with atopic dermatitis and how to properly assess and diagnose pediatric patients’ atopic dermatitis.

Burden of Atopic Dermatitis in Pediatric Patients

Expert pediatric dermatologists Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the burden of pediatric atopic dermatitis.

Pharmacological Options for the Treatment of Pediatric Atopic Dermatitis

Experts treating pediatric atopic dermatitis discuss the pharmacological options for the treatment of pediatric atopic dermatitis.

The Role of Non-Prescription Products in the Management of Acne

In a webinar from the Between the Lines series, 2 dermatology experts discussed challenges in adherence with acne treatments, updates on available moisturizers and cleansers, factors that influence the selection of moisturizers and cleansers for acne-prone patients, and data from 2 studies.

Diagnostic Approaches for Melasma and Vitiligo

Pigmentary disorders of the skin can be the cause of significant psychological distress in affected patients.